Promote a Clinical Trial


Continued Access to RXDX-105

This study is being done to see if people with Non-Small Cell Lung Cancer (NSCLC) or ovarian cancer benefit from continued treatment with the study drug, RXDX-105.

Sponsored by: Memorial Sloan Kettering Cancer Center